{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T15:43:48Z","timestamp":1768837428020,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,14]],"date-time":"2027-01-14T00:00:00Z","timestamp":1799884800000},"content-version":"am","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R38HL167238"],"award-info":[{"award-number":["R38HL167238"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021528","name":"Advancing a Healthier Wisconsin Endowment","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.clml.2025.07.002","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:14:49Z","timestamp":1752610489000},"page":"26-33","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Multistakeholder Qualitative Analysis of Barriers to Autologous Stem Cell Transplantation for Multiple Myeloma"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7447-6173","authenticated-orcid":false,"given":"James Fan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8953-070X","authenticated-orcid":false,"given":"Idayat M.","family":"Akinola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1092-5643","authenticated-orcid":false,"given":"Anita","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6252-6516","authenticated-orcid":false,"given":"Rachel","family":"Cusatis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.clml.2025.07.002_bib0001","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1002\/cncr.30747","article-title":"Hispanics have the lowest stem cell transplant utilization rate for autologous hematopoietic cell transplantation for multiple myeloma in the United States: a CIBMTR report","volume":"123","author":"Schriber","year":"2017","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.clml.2025.07.002_bib0002","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jtct.2023.08.028","article-title":"Overcoming barriers to autologous stem cell transplantation in multiple myeloma: recommendations from a multidisciplinary roundtable discussion","volume":"29","author":"Bashir","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"12","key":"10.1016\/j.clml.2025.07.002_bib0003","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.bbmt.2020.09.013","article-title":"Barriers to hematopoietic cell transplantation for adults in the United States: a systematic review with a focus on age","volume":"26","author":"Flannelly","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.clml.2025.07.002_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.beha.2023.101480","article-title":"Reducing barriers of access and care related to hematopoietic cell transplantation and cellular therapy: the mission-driven role of the national marrow donor program","volume":"36","author":"Yusuf","year":"2023","journal-title":"Best Pract Res Clin Haematol"},{"issue":"8","key":"10.1016\/j.clml.2025.07.002_bib0005","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv139","article-title":"The real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma","volume":"107","author":"Winn","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.clml.2025.07.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-024-01067-x","article-title":"Factors determining utilization of stem cell transplant for initial therapy of multiple myeloma by patient race: exploring intra-racial healthcare disparities","volume":"14","author":"Ailawadhi","year":"2024","journal-title":"Blood Cancer J"},{"issue":"9","key":"10.1016\/j.clml.2025.07.002_bib0007","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1016\/j.clml.2019.05.003","article-title":"A mixed-methods study of stem cell transplantation utilization for newly diagnosed multiple myeloma","volume":"19","author":"Fiala","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"6","key":"10.1016\/j.clml.2025.07.002_bib0008","doi-asserted-by":"crossref","first-page":"e598","DOI":"10.3747\/co.23.3298","article-title":"Risk stratification, treatment selection, and transplant eligibility in multiple myeloma: a qualitative study of the perspectives and self-reported practices of oncologists","volume":"23","author":"LeBlanc","year":"2016","journal-title":"Curr Oncol"},{"key":"10.1016\/j.clml.2025.07.002_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.974038","article-title":"Decision-making factors for an autologous stem cell transplant for older adults with newly diagnosed multiple myeloma: a qualitative analysis","volume":"12","author":"Mian","year":"2023","journal-title":"Front Oncol"},{"issue":"8","key":"10.1016\/j.clml.2025.07.002_bib0010","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3390\/cancers15082369","article-title":"What affects treatment underuse in multiple myeloma in the United States: a qualitative study","volume":"15","author":"Cytryn","year":"2023","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.clml.2025.07.002_bib0011","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.3390\/healthcare12161587","article-title":"Patient perspectives on social and identity factors affecting multiple myeloma care: barriers and opportunities","volume":"12","author":"Neparidze","year":"2024","journal-title":"Healthcare"},{"issue":"3","key":"10.1016\/j.clml.2025.07.002_bib0012","first-page":"1167","article-title":"Patient housing barriers to hematopoietic cell transplantation: results from a mixed-methods study of transplant center social workers","volume":"24","author":"Preussler","year":"2016","journal-title":"Support Care Cancer"},{"issue":"9","key":"10.1016\/j.clml.2025.07.002_bib0013","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","year":"2005","journal-title":"Qual Health Res"},{"issue":"11","key":"10.1016\/j.clml.2025.07.002_bib0014","first-page":"4253","article-title":"Caregiver availability and patient access to hematopoietic cell transplantation: social worker perspectives inform practice","volume":"27","author":"Preussler","year":"2019","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clml.2025.07.002_bib0015","unstructured":"Recognize, Assist, include, support, & engage (RAISE) Family Caregivers Act Advisory Council. 2024 [Accessed: January 10, 2025 ]; Available at: https:\/\/acl.gov\/programs\/support-caregivers\/raise-family-caregiving-advisory-council."},{"issue":"3","key":"10.1016\/j.clml.2025.07.002_bib0016","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/s13187-020-01882-3","article-title":"An iterative formative evaluation of medical education for multiple myeloma patients receiving autologous stem cell transplant","volume":"37","author":"Halpin","year":"2022","journal-title":"J Cancer Educ"},{"issue":"2","key":"10.1016\/j.clml.2025.07.002_bib0017","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2204925","article-title":"Triplet therapy, transplantation, and maintenance until progression in myeloma","volume":"387","author":"Richardson","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.clml.2025.07.002_bib0018","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.3390\/curroncol29070358","article-title":"Quality of online information on multiple myeloma available for laypersons","volume":"29","author":"Staemmler","year":"2022","journal-title":"Current Oncol"},{"issue":"4","key":"10.1016\/j.clml.2025.07.002_bib0019","doi-asserted-by":"crossref","DOI":"10.1038\/s41408-022-00671-z","article-title":"Financial toxicity in hematological malignancies: a systematic review","volume":"12","author":"Ouchveridze","year":"2022","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.clml.2025.07.002_bib0020","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1200\/OP-24-00454","article-title":"Cost conversations to mitigate the effects of financial toxicity in oncology: current State, opportunities, and barriers","volume":"21","author":"Littman","year":"2025","journal-title":"JCO Oncol Pract"},{"issue":"9","key":"10.1016\/j.clml.2025.07.002_bib0021","doi-asserted-by":"crossref","first-page":"e1494","DOI":"10.1200\/OP.22.00056","article-title":"Financial toxicity intervention improves outcomes in patients with hematologic malignancy","volume":"18","author":"Knight","year":"2022","journal-title":"JCO Oncol Pract"},{"issue":"10","key":"10.1016\/j.clml.2025.07.002_bib0022","doi-asserted-by":"crossref","first-page":"e1433","DOI":"10.1200\/OP.21.00124","article-title":"Levine Cancer Institute financial toxicity tumor board: a potential solution to an emerging problem","volume":"17","author":"Raghavan","year":"2021","journal-title":"JCO Oncol Pract"},{"issue":"1","key":"10.1016\/j.clml.2025.07.002_bib0023","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1200\/OP-24-00598","article-title":"Development and validation of a simplified financial toxicity screening tool for use in clinical practice","volume":"21","author":"Thom","year":"2025","journal-title":"JCO Oncol Pract"},{"issue":"2","key":"10.1016\/j.clml.2025.07.002_bib0024","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/curroncol31020068","article-title":"Interventions to mitigate financial toxicity in adult patients with cancer in the United States: a scoping review","volume":"31","author":"Villalona","year":"2024","journal-title":"Current Oncol"},{"issue":"8","key":"10.1016\/j.clml.2025.07.002_bib0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/ajh.23753","article-title":"Use of autologous hematopoietic cell transplantation as initial therapy in multiple myeloma and the impact of socio-geo-demographic factors in the era of novel agents","volume":"89","author":"Al-Hamadani","year":"2014","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.clml.2025.07.002_bib0026","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbmt.2013.10.004","article-title":"Geographic distance is not associated with inferior outcome when using long-term transplant clinic strategy","volume":"20","author":"Ragon","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"10.1016\/j.clml.2025.07.002_bib0027","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.bbmt.2016.03.019","article-title":"Association of distance from transplantation center and place of residence on outcomes after allogeneic hematopoietic cell transplantation","volume":"22","author":"Khera","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.clml.2025.07.002_bib0028","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.bbmt.2011.08.022","article-title":"The impact of geographic proximity to transplant center on outcomes after allogeneic hematopoietic stem cell transplantation","volume":"18","author":"Abou-Nassar","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9","key":"10.1016\/j.clml.2025.07.002_bib0029","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3109\/10428194.2015.1011156","article-title":"Socioeconomic status is independently associated with overall survival in patients with multiple myeloma","volume":"56","author":"Fiala","year":"2015","journal-title":"Leukemia & Lymphoma"},{"issue":"12","key":"10.1016\/j.clml.2025.07.002_bib0030","doi-asserted-by":"crossref","first-page":"1189.e1","DOI":"10.1016\/j.jtct.2024.09.010","article-title":"Racial and ethnic disparities in autologous hematopoietic cell transplantation utilization in multiple myeloma have persisted over time even after referral to a transplant center","volume":"30","author":"Wu","year":"2024","journal-title":"Transplant Cell Ther"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025002381?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265025002381?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T10:52:37Z","timestamp":1768387957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265025002381"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2152265025002381"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2025.07.002","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Multistakeholder Qualitative Analysis of Barriers to Autologous Stem Cell Transplantation for Multiple Myeloma","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2025.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}